Metformin Use Associated With Lower Death Risk in Type 2 Diabetes
In a study of patients with type 2 diabetes at high cardiovascular (CV) risk, metformin use decrease the risk of all-cause mortality but had no significant effect on a composite end point of CV death, MI, or ischemic stroke.